In Depth: Lean Times Ahead for Producers of Weight-Loss Drugs

A new class of drugs has transformed weight loss worldwide, for those that can afford it. GLP-1 receptor agonists mimic a gut hormone to boost insulin release, slow digestion and curb hunger.

Since 2023, two firms have turned these drugs into blockbusters.